HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia.

AuthorsRidvan Ali, Meral Beksac, Fahir Ozkalemkas, Vildan Ozkocaman, Atilla Ozkan, Tulay Ozcelik, Ahmet Tunali
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 48 Issue 7 Pg. 1426-8 (Jul 2007) ISSN: 1042-8194 [Print] United States
PMID17613776 (Publication Type: Case Reports, Comment, Letter)
Chemical References
  • Boronic Acids
  • Pyrazines
  • Bortezomib
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Boronic Acids (therapeutic use)
  • Bortezomib
  • Humans
  • Leukemia, Plasma Cell (drug therapy)
  • Male
  • Middle Aged
  • Multiple Myeloma (pathology)
  • Neoplasms, Second Primary (diagnosis, drug therapy)
  • Pyrazines (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: